title: Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy.
abstract: Intravenous immune-globulin (IVIG) use in renal transplantation has increased, with common uses including desensitization, treatment of antibody mediated rejection and adjunctive therapy for BK virus nephropathy. Although considered generally safe, potential side effects can occur in up to 23% of patients including acute kidney injury. We present a case of an unexpected cause of acute kidney injury in a renal transplant recipient following IVIG infusion. A 48-year-old nonsensitized female with end stage renal disease secondary to polycystic kidney disease received a deceased donor kidney transplant. The initial post-transplant period was unremarkable however at three years post-transplant the patient develops BK virus nephropathy. Despite a reduction in immunosuppression, graft function worsened and IVIG infusion was commenced. Immediately following the IVIG infusion, the patient develops anuric acute kidney injury necessitating hemodialysis. Renal transplant biopsy performed before and after the IVIG infusion revealed the de novo development of acute antibody mediated rejection and donor specific antibodies in the serum. Anti-HLA and donor-specific antibodies were also confirmed in a diluted sample of the IVIG preparation. We argue that the anti-HLA antibodies present in the IVIG caused an acute antibody mediated rejection in this previously nonsensitized female.
authors.affiliation: Division of Nephrology, Saskatchewan Transplant Program, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Rahul.mainra@usask.ca
authors.forename: R
authors.initials: R
authors.lastname: Mainra
authors.forename: Q
authors.initials: Q
authors.lastname: Xu
authors.forename: R
authors.initials: R
authors.lastname: Chibbar
authors.forename: A
authors.initials: A
authors.lastname: Hassan
authors.forename: A
authors.initials: A
authors.lastname: Shoker
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology* / Q000276:immunology / Q000821:virology; D001739:BK Virus / Q000276:immunology; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D007668:Kidney / Q000473:pathology / Q000601:surgery; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery; D016030:Kidney Transplantation; D008875:Middle Aged; D007690:Polycystic Kidney Diseases / Q000150:complications; D027601:Polyomavirus Infections / Q000188:drug therapy* / Q000276:immunology; D014412:Tumor Virus Infections / Q000188:drug therapy* / Q000276:immunology
chemical_list: D016756:Immunoglobulins, Intravenous
keywords: Adverse effects; Antibody-mediated rejection; BK nephropathy; Intravenous immunoglobulin; Renal transplant